Twist Bioscience (TWST) Preferred Stock Liabilities (2017 - 2018)
Twist Bioscience (TWST) reported Preferred Stock Liabilities of $290.5 million for Q3 2018, up 1021.56% quarter-over-quarter from $25.9 million in Q2 2018.
Twist Bioscience (TWST) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends
Twist Bioscience (TWST) has 2 years of Preferred Stock Liabilities data on file, last reported at $290.5 million in Q3 2018.
- Preferred Stock Liabilities for Q3 2018 came in at $290.5 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was $290.5 million (changed N/A YoY), and the FY2018 annual result was $290.5 million, up 690.95% from the prior year.
- Preferred Stock Liabilities rose to $290.5 million in Q3 2018 per TWST's latest filing, from $25.9 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $290.5 million in Q3 2018 and troughed at $9.1 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | Twist Bioscience | 4.30 Bn | 4.30 Bn | 57.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 290.48 Mn |
| Jun 30, 2018 | 25.90 Mn |
| Mar 31, 2018 | 25.90 Mn |
| Dec 31, 2017 | 9.14 Mn |